1.Su, CP, et al. Fusobacterium bacteremia: clinical significance and outcomes. Journal of Microbiology, Immunology and Infection 2009; 42: 336–342.
2.Fanourgiakis, P, et al. Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Supportive Care in Cancer 2003; 11: 332–335.
3.Huggan, PJ, Murdoch, DR. Fusobacterial infections: clinical spectrum and incidence of invasive disease. Journal of Infection 2008; 57: 283–289.
4.Epaulard, O, et al. The changing pattern of Fusobacterium infections in humans: recent experience with Fusobacterium bacteraemia. Clinical Microbiology and Infection 2006; 12: 178–181.
5.Yang, CC, et al. Characteristics and outcomes of Fusobacterium nucleatum bacteremia – a 6-year experience at a tertiary care hospital in northern Taiwan. Diagnostic Microbiology and Infectious Disease 2011; 70: 167–174.
6.Karkos, PD, et al. Lemierre's syndrome: a systematic review. The Laryngoscope 2009; 119: 1552–1559.
7.Hagelskjaer Kristensen, L, Prag, J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. European Journal of Clinical Microbiology & Infectious Diseases 2008; 27: 779–789.
8.Henry, S, DeMaria, A Jr., McCabe, WR. Bacteremia due to Fusobacterium species. American Journal of Medicine 1983; 75: 225–231.
9.Bourgault, AM, et al. Fusobacterium bacteremia: clinical experience with 40 cases. Clinical Infectious Diseases 1997; 25 (Suppl. 2): S181–183.
10.Nohrstrom, E, et al. Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia. Scandinavian Journal of Infectious Diseases 2011; 43: 463–470.
11.Brook, I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. Journal of Infectious Diseases 1989; 160: 1071–1075.
12.Chaim, W, Mazor, M. Intraamniotic infection with fusobacteria. Archives of Gynecology and Obstetrics 1992; 251: 1–7.
13.Guarner, F, Malagelada, JR. Gut flora in health and disease. Lancet 2003; 361: 512–519.
14.Marshall, JC. Gastrointestinal flora and its alterations in critical illness. Current Opinion in Clinical Nutrition & Metabolic Care 1999; 2: 405–411.
15.Citron, DM, Poxton, IR, Baron, EJ. Bacteroides, porphyromonas, prevotella, fusobacterium, and other anaerobic gram-negative rods. In: Murray, PR, et al. , eds. Manual of Clinical Microbiology, 9th edn.Washington, D.C.: ASM Press, 2009, pp. 911–932.
16.Liu, CY, et al. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial Agents and Chemotherapy 2008; 52: 3161–3168.